October 21, 2014 11:35 AM ET


Company Overview of Phosphate Therapeutics Ltd.

Company Overview

Phosphate Therapeutics Ltd. operates as a pharmaceutical company. The company engages in development of drug named PT20 to cure high phosphate levels in blood. Phosphate Therapeutics Ltd. was founded in 2011 and is based in London, United Kingdom. The company operates as a subsidiary of Shield Therapeutics.


United Kingdom

Founded in 2011

Key Executives for Phosphate Therapeutics Ltd.

Chief Executive Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Lonza Biologics PLC Europe
Metris Therapeutics Ltd. Europe
Exeter Antioxidant Therapeutics Ltd. Europe
BBI Enzymes Limited Europe
Archimica Chemicals Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Phosphate Therapeutics Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.